Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1651866
Max Phase: Preclinical
Molecular Formula: C26H31Cl2N3O6
Molecular Weight: 434.37
Molecule Type: Small molecule
Associated Items:
ID: ALA1651866
Max Phase: Preclinical
Molecular Formula: C26H31Cl2N3O6
Molecular Weight: 434.37
Molecule Type: Small molecule
Associated Items:
Synonyms (1): NPC1161B
Synonyms from Alternative Forms(1):
Canonical SMILES: COc1cc(N[C@H](C)CCCN)c2nccc(C)c2c1Oc1ccc(Cl)c(Cl)c1.O=C(O)CCC(=O)O
Standard InChI: InChI=1S/C22H25Cl2N3O2.C4H6O4/c1-13-8-10-26-21-18(27-14(2)5-4-9-25)12-19(28-3)22(20(13)21)29-15-6-7-16(23)17(24)11-15;5-3(6)1-2-4(7)8/h6-8,10-12,14,27H,4-5,9,25H2,1-3H3;1-2H2,(H,5,6)(H,7,8)/t14-;/m1./s1
Standard InChI Key: VWFHXOIAXIAYQN-PFEQFJNWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 434.37 | Molecular Weight (Monoisotopic): 433.1324 | AlogP: 6.19 | #Rotatable Bonds: 8 |
Polar Surface Area: 69.40 | Molecular Species: BASE | HBA: 5 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 10.20 | CX LogP: 4.86 | CX LogD: 2.26 |
Aromatic Rings: 3 | Heavy Atoms: 29 | QED Weighted: 0.44 | Np Likeness Score: -0.39 |
1. Nanayakkara NP, Ager AL, Bartlett MS, Yardley V, Croft SL, Khan IA, McChesney JD, Walker LA.. (2008) Antiparasitic activities and toxicities of individual enantiomers of the 8-aminoquinoline 8-[(4-amino-1-methylbutyl)amino]-6-methoxy-4-methyl-5-[3,4-dichlorophenoxy]quinoline succinate., 52 (6): [PMID:18378716] [10.1128/aac.00645-07] |
2. Dechy-Cabaret O, Benoit-Vical F.. (2012) Effects of antimalarial molecules on the gametocyte stage of Plasmodium falciparum: the debate., 55 (23): [PMID:23075290] [10.1021/jm3005898] |
3. Flannery EL, Fidock DA, Winzeler EA.. (2013) Using genetic methods to define the targets of compounds with antimalarial activity., 56 (20): [PMID:23927658] [10.1021/jm400325j] |
Source(1):